EBITDA expansion.
EBITDA expansion.
Building the healthcare marketing infrastructure that moves the multiple.
Your operating partners don’t measure healthcare marketing.
They measure healthcare EBITDA.
Revenue growth, operational efficiency, patient acquisition cost – every metric that matters to a PE sponsor eventually shows up as a margin number.
Marketing’s problem has never been that it doesn’t create value. It’s that most healthcare marketing agencies can’t prove it in the language that actually gets heard in the boardroom.
The gap between potential and reality is almost always the same: agencies that optimize for engagement and brand awareness report on impressions and cost per lead – and can’t connect what they do to what your operating partners actually measure.
That’s the conversation Agency Creative was built to change.
Healthcare marketing as a margin driver.
The platforms that consistently expand healthcare EBITDA through marketing share one capability: they’ve connected their healthcare marketing infrastructure directly to their financial operating model.
What a new patient or client is worth
Which service mix drives the highest margin per provider hour
Which markets are generating returns, and which are absorbing capital without producing it
That kind of visibility doesn’t happen by accident. It’s built deliberately – measurement system by measurement system, attribution layer by attribution layer.
And once it exists, it changes what marketing can claim in the boardroom.
What we build together.
We call it an exit-ready healthcare marketing model: the infrastructure, strategy, and measurement systems that make marketing’s contribution to EBITDA not just real, but provable.
At the center of that model is RADAR, our investment intelligence platform that shows, location by location, where marketing capital is producing returns and where it isn’t.
RADAR
is not a reporting dashboard. It’s the answer to the question every operating partner eventually asks: where should the next healthcare marketing dollar go?
The goal
grow revenue faster than you grow your marketing budget. Scale production without scaling overhead, and build the systems that make organic growth predictable enough to be bankable.
Connecting every campaign to financial outcomes
Revenue increases, new patient or client value, contribution margin improvement
Scalable growth infrastructure
Performs consistently across your portfolio, not just in your best markets
De Novo efficiency
Same-site revenue optimization
Increases production per location without proportional increases in overhead
Repeatable organic growth systems
Make performance forecastable, and the documented organic growth story that supports valuation multiple expansion at recap or sale
Institutional-grade reporting through RADAR
Our portfolio investment intelligence platform, giving operating partners location-by-location visibility into where marketing capital is working, where it isn’t, and where the next dollar should go
The agencies serving your competitors are optimizing for impressions. The CMOs who win board conversations are optimizing for contribution margin. Those are different jobs. We do the second one.
The valuation story you're building right now.
PE-backed healthcare platforms are always thinking about what comes next – a recap, a platform sale, an add-on strategy, or multiple expansion.
The marketing story you’re building today is the story your sponsors will tell to the next buyer. Organic growth that’s documented, attributable, and repeatable commands a premium. Growth that can’t be explained or reproduced doesn’t.
The marketing agencies serving your competitors are optimizing for clicks. We’re optimizing for contribution margin, and ultimately, for the enterprise value of your platform.
Marketing due diligence, before the deal closes.
We also work upstream, before the portco CMO relationship begins.
PE firms evaluating a healthcare platform acquisition rarely have visibility into the marketing variables that most directly affect post-close performance: whether the target’s CAC is improving or deteriorating, whether attribution infrastructure exists or is being papered over, and how much of the media budget is generating margin versus volume.
Agency Creative’s Marketing Due Diligence surfaces those answers before the deal signs, so the investment committee is pricing real marketing risk, not assuming it away.
What a high-performing partnership looks like.
Healthcare marketing spend treated as a growth investment
With documented ROI, not overhead with soft justification
Board-ready reporting
Shows marketing’s contribution to same-site EBITDA, De Novo ramp compression, blended acquisition cost improvement, and valuation multiple expansion
A marketing model that holds its performance
As the platform grows, rather than requiring proportional budget increases every time you add locations
Strategic alignment across teams
Between marketing, operations, and scheduling or intake teams, so every dollar invested in demand generation converts at the highest possible rate
Your next platform milestone starts now.
Your next recap, sale, or add-on acquisition will require a compelling marketing story.
The time to build that story is now, while there’s runway to prove the model, improve the metrics, and demonstrate the kind of predictable organic growth that commands a premium multiple.
Agency Creative is ready to be that partner. We speak finance. We know what your operating partners are measuring.
We build healthcare marketing campaigns and strategies that map directly to the metrics that matter in your boardroom, and we deliver results that give you the confidence to walk into those meetings and own the room.
Let’s build your value creation story together.
A vision network with multiple brands and over 500 locations is the clearest proof point we can offer. By connecting media investment to same-site revenue density and optimizing toward margin rather than volume, we helped expand EBITDA contribution across their portfolio while holding that blended CPA across channels. That’s the kind of documented healthcare marketing ROI that holds up in a board deck and survives due diligence.
Schedule an Exit-Readiness Assessment.
We’ll evaluate your current healthcare marketing infrastructure against the standards a sophisticated buyer or recapitalization process will apply: attribution integrity, organic growth consistency, CAC trajectory, and the provability of EBITDA contribution.
You’ll leave with a clear picture of where your marketing story is strong, where it has gaps, and what it would take to close them before the next milestone.
